- Home
- ESP vs AVTX Comparison
ESP vs AVTX Comparison
Compare ESP & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- AVTX
- Stock Information
- Founded
- ESP 1928
- AVTX 2011
- Country
- ESP United States
- AVTX United States
- Employees
- ESP N/A
- AVTX N/A
- Industry
- ESP Industrial Machinery/Components
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ESP Technology
- AVTX Health Care
- Exchange
- ESP Nasdaq
- AVTX Nasdaq
- Market Cap
- ESP 129.5M
- AVTX 57.4M
- IPO Year
- ESP N/A
- AVTX 2015
- Fundamental
- Price
- ESP $46.29
- AVTX $4.88
- Analyst Decision
- ESP
- AVTX Strong Buy
- Analyst Count
- ESP 0
- AVTX 7
- Target Price
- ESP N/A
- AVTX $31.00
- AVG Volume (30 Days)
- ESP 33.4K
- AVTX 99.0K
- Earning Date
- ESP 05-12-2025
- AVTX 08-11-2025
- Dividend Yield
- ESP 2.13%
- AVTX N/A
- EPS Growth
- ESP 39.20
- AVTX N/A
- EPS
- ESP 2.67
- AVTX N/A
- Revenue
- ESP $45,965,588.00
- AVTX $441,000.00
- Revenue This Year
- ESP N/A
- AVTX N/A
- Revenue Next Year
- ESP N/A
- AVTX N/A
- P/E Ratio
- ESP $17.40
- AVTX N/A
- Revenue Growth
- ESP 29.60
- AVTX N/A
- 52 Week Low
- ESP $20.50
- AVTX $3.39
- 52 Week High
- ESP $48.71
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- ESP 69.64
- AVTX 56.99
- Support Level
- ESP $45.94
- AVTX $4.63
- Resistance Level
- ESP $48.24
- AVTX $4.99
- Average True Range (ATR)
- ESP 1.87
- AVTX 0.28
- MACD
- ESP 0.07
- AVTX 0.01
- Stochastic Oscillator
- ESP 74.61
- AVTX 87.64
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).